Filing Details

Accession Number:
0000905148-25-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-03 17:23:14
Reporting Period:
2024-12-31
Accepted Time:
2025-01-03 17:23:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1836195 Kai-Xian Chen C/O Zai Lab Limited
314 Main Street, 4Th Floor, Suite 100
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2023-01-03 2,644 $30.70 68,528 No 4 F Direct
American Depositary Shares Disposition 2024-07-01 7,750 $17.22 60,778 No 4 S Direct
American Depositary Shares Disposition 2024-12-31 21,253 $0.00 39,525 No 4 D Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 D Direct
Footnotes
  1. Each American Depositary Share (ADS) represents ten Ordinary Shares of the Issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
  2. Represents the disposition of shares to the Issuer to cover taxes.
  3. These ADSs were sold automatically to cover taxes.
  4. Represents the forfeiture of the unvested restricted shares upon the Reporting Person's resignation from the Issuer's board of directors on December 31, 2024.
  5. Reflects the number of ADSs beneficially owned by the Reporting Person following the transaction reported in the last Form 4 of the Reporting Person, which was filed on June 20, 2024, as adjusted for this transaction.